Enacting the right to try for individualized treatments act to permit a manufacturer to make an individualized investigative treatment available to a requesting patient.

Introduced

In Committee

Floor

Crossed Over

Passed

Enacted

Overview Bill text 3 Compare versions History 21 Sponsors

No sponsors recorded.

PASSAGE PROBABILITY

15.6% Unlikely

Why this number

Stage base Passed First Chamber — base rate 35%, measured from KS's completed sessions
Momentum +2 60/100 from the pace of recorded action
Time since last action -22 610 days quiet

A transparent scoring model over stage, momentum, recency, sponsorship and recorded votes — not a trained predictor. Treat it as a way to rank attention, not as a forecast.